Portfolio

 

Augmenix™, Inc. is a privately held medical device company developing in-situ formed, space-filling hydrogels specifically for radiation oncology and cancer surgery indications.  Augmenix, Inc.'s initial product will be the first synthetic tissue spacer designed and indicated to reduce radiation exposure of normal tissues adjacent to prostate cancers.
www.augmenix.com

 

 

Hepregen Corporation is developing bioengineered solutions for drug development, including a platform for advanced toxicity screening and drug discovery.
www.hepregen.com

 

 

Allegro Diagnostics, Inc. is a molecular diagnostics company using proprietary technology and bioinformatics to diagnose diseases of epithelial origin, such as lung cancer.
www.allegrodiagnostics.com

 

 

BioTrove, Inc.

Biotrove's mission is to advance Life Science and Drug Discovery research by leveraging micro and nano-scale technology. Currently, Biotrove offers products and services based on two revolutionary, high throughput technologies: Open Array and Rapid Fire.
www.biotrove.com

Vortex Medical

A specifically designed catheter-based system that facilitates en bloc removal of undesirable intravascular material such as thrombi.

www.angiovac.com

 

 

Hansen Medical makes an electromechanical robotic system which provides accurate and efficient control over catheter movement during interventional procedures. The system is controlled by the physician from a workstation that integrates visualization, guidance, and patient physiologic data.
www.hansenmedical.com

 

 

GI Dynamics develops innovative products for the treatment of obesity and its complications. The main product is a removable sleeve introduced into the digestive tract of a patient to treat obesity and diabetes
www.gidynamics.com

 

 

LumeRx is a medical device company developing novel light-based therapies for the treatment of diseases caused by bacterial and other pathogenic infections. Its first device will deliver a specific wavelength of light to the stomach to eradicate h. pylori, the bacteria causing peptic ulcer disease (PUD) and believed to be the cause of gastric cancer.
www.lumerx.com

 

 

Castel, Inc. has developed and markets enterprise software for call center applications. Castel's technology enables tight integration of CRM and telephony functions in both inbound, outbound and mixed call centers.
www.castel.com

 

 

Novazyme was an early stage Pharmaceutical company developing biotherapies for the treatment of lysosomal storage disorders. Novazyme was acquired by Genzyme Corporation in 2001.

 

 

EndoVia Medical, Inc. (formerly Brock Rogers Surgical, Inc.) was a medical device company developing an integrated system to guide and control "intelligent" computer assisted disposable instruments. EndoVia Medical was acquired by Hansen Medical in 2005.

Seedling Enterprises, LLC.

Seedling Enterprises, LLC ('Seedling') is a medical device incubator founded by respected and experienced medical device executives and entrepreneurs, to invest in develop and commercialize innovative medical products, platform technologies, and leading-edge healthcare businesses. Seedling Enterprises holds an interest in GI Dynamics, Inc., LumeRx, Inc., and Angstrom Medical, Inc.

 

 

                                                                                                                                                                            

BIOCIUS Life Sciences, Inc. is a privately held company committed to collaborating with researchers to advance drug discovery research. Using RapidFire® technology, BIOCIUS helps to eliminate bottlenecks for lead discovery and in vitro ADME . The RapidFire system enables researchers to gain a more complete understanding of the biochemical properties of potential lead compounds, including potential liabilities in drug-drug interactions using high-throughput mass spectrometry (MS). BioTrove's OpenArray™ business was acquired by Life Technologies (NASDAQ: LIFE). 

www.lifetechnologies.com